The objective of this study is to promote the rational drug use of Thailand. E List, clause 2 for specific patients is added in the National List of Essential Medicines, 2551 B.E. Ten medicines, which require knowledge, specialization in disease or advanced technology, are included in the list. However, it is likely that the prescription of these m

63351001RM001L0evaluation,health service system,health system,การประเมิน,ระบบบริการสุขภาพ,ระบบสุขภาพ,สร้างเสริมสุขภาพ

The Government of the Democratic People’s Republic of Korea (DPR Korea) was one of the first countries to successfully apply for Gavi, the Vaccine Alliance’s (Gavi) new funding window on health systems strengthening (HSS) in 2006 and was subsequently awarded a second Gavi HSS grant in 2014. The Heal

This research project assesses the implementation of a pilot project of screening of Down’s syndrome in primary healthcare facilities in five provinces including Chiang Mai, Lamphun, Nakhon Sawan, Khon Kaen, and Songkhla. Findings from the assessment will be used to improve the service delivery as well as to explore possibilities of scaling up th

As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about

Generic reference cases for economic evaluation (EE) of “cure-based” health technologies may not fit into the new healthcare paradigm of precision medicine (PM). Current EE approaches were challenged by the complex evolving decision space of PM, lack of clinical evidence due to small patient cluster

\"First Step”, a program evaluation report, assessing HITAP’s two-year efforts and providing recommendations for further development of HITAP. This program evaluation was conducted by four external evaluators including Prof. John Cairns, Dr. Kalipso Chalkidou, Prof. Paibul Suriyawongpaisal, and Dr. Jirawat Panpiemras. Moreover, Prof. Mark Sculp

(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Thavorncharoensap M1, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P 1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand ; Heal

The Thai healthcare system faces pressure to fund high-cost new branded pharmaceuticals. Paying more may encourage innovation with positive implications for future population health, but it also means less money is available to fund other healthcare with negative implications for current population